These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12756822)

  • 1. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to establish GCP-units in Denmark?].
    Krogsgaard K; Andreasen PB
    Ugeskr Laeger; 2003 Apr; 165(16):1665-7. PubMed ID: 12756825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspection of clinical investigations by the German health authorities.
    Schmidt M
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):229-31. PubMed ID: 8361260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reporting adverse reactions and events in randomised clinical trials].
    Hemmingsen B; Støy L; Wetterslev J; Tarnow L; Friis KB; Christensen LL; Sales N; Gluud C;
    Ugeskr Laeger; 2010 Aug; 172(35):2381-4. PubMed ID: 20825743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Responsibilities of ethics committees].
    von Bergmann K
    Med Klin (Munich); 2000 May; 95(1 Spec No):15-7. PubMed ID: 10851843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical drug trials. Regulation, coordination and significance of "Good Clinical Practice"].
    Hvidberg EF
    Ugeskr Laeger; 1994 Feb; 156(6):789-93. PubMed ID: 8016980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conducting clinical trials in Singapore.
    Woo KT
    Singapore Med J; 1999 Apr; 40(4):310-3. PubMed ID: 10487091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attitude of patient associations to clinical trials of new drugs].
    Tybkjaer HW; Witte L; Johannessen MB
    Ugeskr Laeger; 2003 Apr; 165(16):1688-90. PubMed ID: 12756833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiencies in proposed new EU regulation of clinical trials.
    Gøtzsche PC
    BMJ; 2012 Dec; 345():e8522. PubMed ID: 23258926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Organization, administration, and performance of clinical studies].
    Bachner M; Steininger T; Gneist M
    Onkologie; 2008; 31 Suppl 2():3-6. PubMed ID: 18487861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The scientific committee system].
    Kamper-Jørgensen F
    Ugeskr Laeger; 2003 Apr; 165(16):1680-2. PubMed ID: 12756830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GCP inspections of clinical trials].
    Schwarz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):181-8. PubMed ID: 15726459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Network for investigation of medicinal products in children].
    Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G
    Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.